Symptomatic Exposures Among California Inmates 2011–2013

被引:2
作者
Butterfield M. [1 ]
Al-Abri S. [2 ]
Huntington S. [3 ]
Carlson T. [3 ]
Geller R.J. [3 ]
Olson K.R. [2 ,3 ]
机构
[1] Department of Internal Medicine, Tulane University Medical Center, New Orleans, LA
[2] Division of Clinical Pharmacology and Toxicology, University of California, San Francisco, CA
[3] California Poison Control System, San Francisco and Madera Divisions, Department of Clinical Pharmacy, University of California, San Francisco, CA
关键词
Body stuffer; Drug abuse; Poison control; Prisoner;
D O I
10.1007/s13181-014-0456-6
中图分类号
学科分类号
摘要
Prisoners have a high prevalence of substance misuse and abuse, but few studies have examined symptomatic exposures among incarcerated populations. We sought to further characterize the nature of these exposures among this population using the California Poison Control System data. Keyword searches identified inmate cases in 2011–2013 for patients 20+ years old exposed to a single substance and taken to hospital from jail, prison, or police custody. Comparisons were made with non-inmate cases during the same period, using similar limitations. Body stuffers and body packers were analyzed as a subgroup. Seven hundred four inmate cases were compared to 106,260 non-inmate cases. Inmates were more likely to be younger, male, and to have engaged in drug misuse or abuse. They most commonly ingested methamphetamine, heroin, acetaminophen, and anticonvulsants. Inmates were more likely to receive activated charcoal (OR 9.87, 8.20–11.88), whole bowel irrigation (OR 44.50, 33.83–58.54), undergo endotracheal intubation (OR 4.09, 2.91–5.73), and to experience a major clinical outcome or death (OR 1.41, 1.05–1.89). When body stuffers and packers were removed, clinical findings were similar, though the odds of a major outcome or death became statistically non-significant. Body stuffers and body packers primarily used methamphetamine and heroin, and compared with other inmates had significantly higher odds of both adverse clinical effects and poor outcome. This large series provides a profile of symptomatic exposures among inmates, a little-studied population. The potential for high morbidity among body stuffers and packers suggests that a high index of suspicion of such ingestions be maintained when evaluating patients prior to incarceration. © 2014, American College of Medical Toxicology.
引用
收藏
页码:309 / 316
页数:7
相关论文
共 44 条
[1]  
Bureau of Justice Statistics USD of J Correctional populations in the United States, (2012)
[2]  
Leukefeld C.G., Tims F.R., Drug abuse treatment in prisons and jails, J Subst Abuse Treat, 10, pp. 77-84, (1993)
[3]  
Mumola C., Substance abuse and treatment, state and federal prisoners, (1997)
[4]  
Mumola C., Karberg J., Drug use and dependence, state and federal prisoners, 2004, United States Department of Justice, (2006)
[5]  
Malcolm A.H., Explosive drug use creating new underworld prisons, (1989)
[6]  
Inciardi J.A., Lockwood D., Quinlan J.A., Drug use in prison: patterns, processes, and implications for treatment, J. Drug Issues, (1993)
[7]  
Wohl A.R., Johnson D., Jordan W., Et al., High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers, J Acquir Immune Defic Syndr, 24, pp. 386-392, (2000)
[8]  
Clarke J.G., Stein M.D., Hanna L., Et al., Active and former injection drug users report of HIV risk behaviors during periods of incarceration, Subst Abuse, 22, pp. 209-216, (2001)
[9]  
Prendergast M.L., Campos M., Farabee D., Et al., Reducing substance use in prison: the California department of corrections drug reduction strategy project, Prison J, 84, pp. 265-280, (2004)
[10]  
Del Paggio D., Psychotropic medication abuse in correctional facilities, Bay Area Psychopharmacol Newsl. 2005